Healthcare / Medical Care FacilitiesNSE
$792.85
-16.75 (-2.06%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-1.1B · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
56/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$76.4B
P/E
43.7x
↑EV/EBITDA
24.2x
↑ROE
9.8%
↑Gross Margin
61.1%
↑Debt/Equity
0.15
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+32.4%
FCF CAGR
—
FCF margin
-9.3%
FCF / Net income
-0.64x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $12.07B · net income $1.75B · FCF $-1.12B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $12.07B | $12.07B | $8.86B | $6.71B | $5.20B |
| Net Income | $1.75B | $1.75B | $1.31B | $1.14B | $657.7M |
| EBITDA | $3.18B | $3.18B | $2.36B | $1.96B | $1.37B |
| EPS | — | — | 14.72 | 14.46 | 7.66 |
| Gross Margin | 61.1% | 61.1% | 61.7% | 80.1% | 82.1% |
| Operating Margin | 16.9% | 16.9% | 19.0% | 22.8% | 20.7% |
| Net Margin | 14.5% | 14.5% | 14.7% | 17.1% | 12.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.15 | 0.15 | 0.01 | 0.10 | 1.46 |
| Current Ratio | 3.87 | 3.87 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-1.12B | $-1.12B | $-1.71B | $-964.4M | $439.7M |
| Returns | |||||
| ROE | 9.8% | 9.8% | 8.1% | 13.1% | 35.9% |
| Valuation | |||||
| P/E | 43.66 | 43.66 | 30.69 | 31.65 | — |
| EV/EBITDA | 24.17 | 24.17 | 16.13 | 18.57 | — |
| P/B | 4.29 | 4.29 | 2.50 | 4.15 | — |
| Growth & Yield | |||||
| Revenue Growth | 36.3% | 36.3% | 32.1% | 28.9% | — |
| EPS Growth | — | — | 1.8% | 88.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+55.1%
Start / end P/E
n/dx → n/dx
EPS bridge
14.72 → n/d
Residual
+55.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.